Progression Suppression and Retinal Regression in VEGF-resistant AMD

Clinical trial NCT07005323 · RECRUITING

Trial details

NCT number: NCT07005323
Sponsor: PharmaBio Corporation
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration (AMD)

Start date: 2024-09-12
Primary completion: 2027-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.